Postoperative antithrombin levels and adverse outcome in cardiac operations;
体外循环心脏术后抗凝血酶活性与手术不良结果的相关性
Clinical significance of plasma antithrombin and fibrinolysin in asphyxiated newborns;
抗凝血酶和纤溶功能的变化在窒息新生儿中的临床意义
Significance of the Changes of Plasma vWF,D-dimer and Antithrombin Levels in Patients with Hematological Malignancy;
血液肿瘤患者中血管性血友病因子、D二聚体、抗凝血酶检测的意义
Correlative study between the changes of antithrombin Ⅲ activity & D-dimer level and sequential organ failure assessment score in the patients with sepsis;
脓毒症患者血浆抗凝血酶Ⅲ及D-二聚体与SOFA评分的相关性研究
Screening of Antithrombin Ⅲ(AT-Ⅲ) with High Bioactivity by DNA Shuffling in P.pastoris;
利用DNA改组筛选高活性抗凝血酶Ⅲ
Expression of Soluble Recombinant Human Antithrombin Ⅲ(AT-Ⅲ) inP.pastoris;
人抗凝血酶Ⅲ(AT-Ⅲ)在毕赤酵母中可溶性表达
Immunoresonance Scautering Spectral Assay for the Determination of Antithrombin-Ⅲ;
抗凝血酶Ⅲ的免疫共振散射光谱分析
Antithrombin-Ⅲ concentrations in lung cancer patients were significantly lower(73.
目的对119例肺癌患者D二聚体(D-dimer)和抗凝血酶Ⅲ(antithrombinⅢ,AT-Ⅲ)活性进行检测,以探讨上述指标与肺癌的关系及意义。
The plasmea lever of vWF,GMP-140,TF,FⅡα,AT-Ⅲ and D-Dimer of the subjects were mea.
方法:21例原发性肝癌经肝动脉插管栓塞化疗(TACE)患者分别于插管前(全身)、注射栓塞剂前(局部)、注射栓塞剂后30分钟(局部)、注射栓塞后3小时(全身)以及术后24小时(全身)5个时段,测定血浆TF(组织因子)、vWF(血管性血友病因子)、GMP-140(血浆α-颗粒膜蛋白)、FⅡα(凝血酶)、AT-Ⅲ(抗凝血酶Ⅲ)和D-Dimer(D-二聚体)含量;12名健康志愿者组成正常对照组,同时测定上述指标,对结果进行统计学分析。
After feeding drugs through stomach for one month,tail thrombus models were established by carrageenan in rats except the normal control group,The black tail length,the activ of AT-Ⅲ,the content of D-dimer,the c.
灌胃时间1个月,除正常对照组外,其他3组均用角叉菜胶构建尾部血栓模型,观察不同时间的黑尾长度,抽血查抗凝血酶Ⅲ(AT-Ⅲ)活性、D-二聚体含量、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子α(TNF-α)的含量。
In the review, The dose, caution and adatption of fresh platets, fresh frez en platets, fresh plasma, fresh frozen plasma, prothrombin complex concentrates and fibinogen contentrates as wella as AT-Ⅲ and protein C as anticoagulatory fa ctors are described.
本文对DIC时应用新鲜血小板、新鲜冰冻血小板、新鲜血浆、新鲜冰冻血浆等补充凝血因子、血小板的适应证、应用剂量及注意事项作了总结,并对血液中的抗凝成分抗凝血酶Ⅲ、蛋白C在DIC中的应用现状进行了概述。
The effect of antithrombinⅢ on endotoxininduced multiple organ dysfunction syndrome;
抗凝血酶Ⅲ防治内毒素血症致多器官功能不全的实验研究
Study on the Relationship of Mutation of Prothrombin G20210A,Activated Protein C Resistance and Antithrombin in Patients with Coronary Heart Disease;
凝血酶原G20210A突变、抗活化蛋白C和抗凝血酶与冠心病关系的研究
APPLICATION OF THROMBIN-ANTITHROMBIN COMPLEX IN TREATMENT OF PATIENTS WITH ACUTE AND ANXIETY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
凝血酶-抗凝血酶复合物等在慢性阻塞性肺疾病急性加重期的应用
The Value of Thrombin-antithrombin Ⅲ for Evaluating Thromboembolic Risk and Anticoagulant Treatment in Patients with Atrial Fibrillation;
凝血酶-抗凝血酶Ⅲ在评价房颤患者血栓栓塞危险性及抗凝治疗中的价值
The Diagnostic Significance of Antithrombin in Disseminated Intravascular Coagulation (DIC)
抗凝血酶活性检测在诊断弥散性血管内凝血中的意义
A Study on the Deficiency of Plasma PC Proteins and AT-Ⅲ in Chinese Patients with Budd-Chiari Syndrome;
布-加综合征血浆蛋白C、抗凝血酶-Ⅲ测定
Study on Clinical and Pathologic Mechanism of Hereditary Antithrombin Deficiency;
遗传性抗凝血酶缺陷症的临床与发病机理研究
Quantitative Coupling of Human Antithrombin Mutations with Their Clinical Outcomes
定量联结人抗凝血酶的变异及其临床表现(英文)
Production of Monoclonal Antibodies to Human Antithrombin Ⅲ and Its Primary Application;
抗—人抗凝血酶Ⅲ单克隆抗体的制备及其初步应用
Preparation and Characteristics of High Performance Affinity Chromatography Medium Used for the Separation of Antithrombin Ⅲ
一种分离抗凝血酶Ⅲ的高效亲和色谱填料的制备及表征
Effect of exercise on antithrombin III and adhesive proteins in aged diabetic Patients
运动对老年糖尿病人抗凝血酶Ⅲ及粘附蛋白的影响
Expression and DNA Shuffling of Recombinant Human Antithrombin Ⅲ (AT-Ⅲ) in Pichia Pastoris;
抗凝血酶Ⅲ在巴斯德毕赤酵母中的表达及DNA改组研究
Preparation of Heparin Modified Gold Nanoparticles and Its Application in Detecting Antithrombin Ⅲ
肝素金纳米粒子的制备及其对抗凝血酶Ⅲ（ATⅢ）的识别
Use of EDTA Samples for Prothrombin time Measurement
使用EDTA抗凝血检测凝血酶原时间
The clinical study of prothrombin precursor protein in monitoring anticoagulation
凝血酶原前体蛋白在抗凝监测中的临床研究
Detection of Thrombin Receptor by Alkaline Phosphatase Antialkaline Phosphatase Method
利用碱性磷酸酶抗碱性磷酸酶法检测凝血酶受体
Haemocoagulase Atrox during Tooth Extraction in Patients with Anticoagulation Therapy
注射用血凝酶在抗凝血治疗患者拔牙术中的应用
tissue thromboplasti
组织促凝血酶原激酶
thromboplastin antecedent
促凝血酶原激酶先质